Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
about
A critical role for OX40 in T cell-mediated immunopathology during lung viral infectionThe Differentiation of CD4(+) T-Helper Cell Subsets in the Context of Helminth Parasite InfectionThe role of B cells in the development of CD4 effector T cells during a polarized Th2 immune responseImpact of the TCR signal on regulatory T cell homeostasis, function, and traffickingControl of immunity by the TNFR-related molecule OX40 (CD134)A novel helper role for CD4 T cellsGeneration and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice.OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.The significance of OX40 and OX40L to T-cell biology and immune disease.OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation.New insights on OX40 in the control of T cell immunity and immune tolerance in vivoOx40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.OX40 costimulation turns off Foxp3+ Tregs.OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice.T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines.Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization.Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor TherapyCostimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo.Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40.OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia.Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood.Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus.OX40 signaling favors the induction of T(H)9 cells and airway inflammationOX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.Thymic OX40 expression discriminates cells undergoing strong responses to selection ligands.Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory virusesOX40L-OX40 Interactions: A Possible Target for Gastrointestinal Autoimmune Diseases.The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice.OX40 is required for regulatory T cell-mediated control of colitis.T cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation.Activation and Costimulation of Intestinal T Cells: Independent and Collaborative Involvement of CD43, OX40, and Ly-6C.Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease.An OX40/OX40L interaction directs successful immunity to hepatitis B virus.
P2860
Q24672415-3F6EEB37-8B8A-478D-861A-0EE158C76D16Q26866318-7FF805C5-223A-424D-AEFF-C7FC7AFDD9BCQ33296970-1CDE9CD9-A0EF-4BFF-8092-8F5BAA01D837Q33492305-31FE601B-615F-41A3-9620-7C45A5BEDF02Q33899607-70EAB8D1-B52B-4DC9-8876-6EAE1A0D00ABQ34087699-55B7CB1A-6B79-4C47-8C4A-114490FDF078Q34326036-9B481991-778A-48B1-94C6-65D161558454Q34477650-A5724EC9-9B05-4689-A6B4-887958981111Q34599954-582C3546-17A6-4394-9B06-840B57463B84Q34979946-670D935A-2D23-44BB-AEE7-CF81C64BA2C0Q35118177-EC665809-4D49-4AC8-ACE9-0CAFB83F7E50Q35202632-39D96F13-FD1C-4D01-ABBA-EE884E5C2918Q35685810-09EAA85D-6A45-4BEA-A9F2-D59AF68F914FQ35760061-FE7D87EE-27E9-4177-AD2B-D9A8CBAD84D5Q36007580-BA1AD83F-3DD1-47E4-9B3A-4E74B9C9209CQ36099421-0B6EF977-D16F-4376-AC3E-DA7F4CA8E7CDQ36170783-03A2EB52-192F-4FC1-83E1-5F14B654E04EQ36202186-4235217B-1F09-4D45-A660-799D63349135Q36251308-B36B1AC9-2C2D-43CB-89D0-560DCDE6F492Q36349514-8C4E3C6E-D5E5-498F-8969-860F7EF2C22EQ36370731-F0831F5A-2676-4F10-9BD6-1FA29A808675Q36376225-42A9EA08-DB81-4A5D-A80C-8EAA2C52D879Q36759480-0E577F84-1B93-499A-BE12-5C7F75E83BCEQ37125732-AB40624D-1607-423D-AABF-E6C9D69B2DD0Q37177498-73E266F7-1C5F-4B89-B19B-502BDF1DA077Q37249618-CC87A892-C437-4EE2-81B8-2561492754A9Q37273138-0209669B-9E30-442B-BD51-72C847248669Q37330125-F4BEA623-A066-4EF7-B3A9-65FD2C13A656Q37727208-3104A7AC-C93D-493F-8AA9-2F437FA60E2BQ37948126-A707A4B8-072C-4DA8-B4F9-4037DA2793FFQ38062540-5763F40C-8E89-4C46-9F28-89504CF39D64Q38684474-25B4CD8B-8DDD-457B-9999-F8862B4D0981Q39655881-1BB8E073-2BCC-4427-BE86-560D44190F07Q40066564-23D58D3E-FAEB-4C68-860F-56F4C9246DA6Q41895228-C21FE273-99B7-4962-9E51-C7BF0FA7309EQ43230147-B0144A5C-DA90-4FDA-83C1-AAA712B8C3CEQ43708681-447522E9-480E-4EAF-9FB8-EDA6476C3C09Q47275317-B1643F7C-187A-4AA0-B764-AD41005C1428Q51964553-E17BCBE2-32C2-47AD-BFEA-F6C480A64050Q52644026-00738C5A-B5F9-4BEB-8848-24A8AA9FD948
P2860
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
description
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/12/15)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/12/15)
@nl
наукова стаття, опублікована в грудні 1999
@uk
مقالة علمية (نشرت في 15-12-1999)
@ar
name
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@ast
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@en
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@nl
type
label
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@ast
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@en
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@nl
prefLabel
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@ast
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@en
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@nl
P2093
P1476
Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)
@en
P2093
Barclay AN
Birkeland ML
Godfrey WR
Locksley RM
Peña-Rossi C
P304
P407
P577
1999-12-01T00:00:00Z